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ABSTRACT The body of human genomic and proteomic evidence continues to grow at ever-increasing
rates, while annotation efforts struggle to keep pace. A surprisingly small fraction of human genes have
clear, documented associations with speciﬁc functions, and new functions continue to be found for
characterized genes. Here we assembled an integrated collection of diverse genomic and proteomic data
for 21,341 human genes and make quantitative associations of each to 4333 Gene Ontology terms. We
combined guilt-by-proﬁling and guilt-by-association approaches to exploit features unique to the data
types. Performance was evaluated by cross-validation, prospective validation, and by manual evaluation
with the biological literature. Functional-linkage networks were also constructed, and their utility was
demonstrated by identifying candidate genes related to a glioma FLN using a seed network from genome-
wide association studies. Our annotations are presented—alongside existing validated annotations—in








An abundance of high-throughput laboratory techniques and compu-
tational methods has led to a deluge of human genomic and proteomic
data (Bieri et al. 2007; Crosby et al. 2007; Eppig et al. 2007; Nash et al.
2007). Even when an individual researcher can assemble all available
evidence, they are left with the task of weighing this evidence to infer
likely functions for genes of interest.
Fewer than one-third of human genes have a Gene Ontology (GO)
annotation based on evidence derived from speciﬁc study of that gene
(as opposed to prediction; see Figure 2), providing little guidance to
researchers wanting to investigate sparsely annotated genes. Compu-
tational integration of diverse evidence can help in assigning function,
and ideally these inferences can reﬂect the shades of gray in our
current knowledge, as opposed to the “black or white” annotation that
is most appropriate for archival annotation.
Automated annotation has traditionally relied on sequence
similarity to transfer function from one gene to another, but
homology-based approaches fail in the common scenario in which
a gene/function relationship is unknown or poorly characterized in all
detectable homologs. Toward complementary approaches, integration
of diverse data types have been adopted for use in making predictions
of gene function (Troyanskaya et al. 2003; Deng et al. 2004; Joshi et al.
2004; Karaoz et al. 2004; Lanckriet et al. 2004; Wong et al. 2004;
Huttenhower et al. 2009; Linghu et al. 2009; Bologna et al. 2011)
and modeling term-to-term relationships [(King et al. 2003; Sokolov
and Ben-Hur 2010); see refs. (Murali et al. 2006) and (Huttenhower
and Hofmann 2010) for general reviews on the concepts]. For exam-
ple, one large effort (‘MouseFunc’) was undertaken by a consortium of
research groups to compare function prediction methods using stan-
dardized training and testing datasets for Mus musculus (Pena-Castillo
et al. 2008).
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inferred quantitative associations between 21,341 human genes
(12,925 of which had no existing associations on the basis of di-
rect–ie, nonpredicted–evidence) and each of 4333 GO terms. Our
models exploit both gene features and gene2gene relationships by
using both guilt-by-proﬁling (GBP) and guilt-by-association
(GBA) approaches to function prediction (Taşan et al. 2008; Tian
et al. 2008). We provide estimates of our models’ accuracy, in-
cluding a prospective evaluation in which we consider annotations
that were made after our training data set was assembled. Litera-
ture-based follow-up investigations are performed for a sample of
high-conﬁdence novel predictions. In the course of making these
predictions, we constructed multiple functional linkage networks
[FLNs–where an edge between two genes indicates some level of
shared function (Lee et al. 2004)], capturing different categories of
biological relationships. We ﬁnd that FLNs are independently useful,
which we illustrate here by identifying candidate glioma-related
genes given only “seed” glioma-related genes identiﬁed from sys-
tematic unbiased genome-wide association (GWA) studies. All
gene/term prediction scores from this project—as well as our
FLNs—are made freely available to the public via a web-accessible
resource (Beaver et al. 2010), which has been adapted here to host
quantitative function annotations for H. sapiens.
MATERIALS AND METHODS
Genomic data integration
Genes: We used 36,396 Ensembl Gene IDs as the initial set of
identiﬁers for H. sapiens genes, which was further reduced to 21,341
genes as described in the section Predictive features. All mappings
between alternative identiﬁers and Ensembl Gene IDs were performed
using the Synergizer translation resource (Berriz and Roth 2008).
Predictive features: We downloaded 6121 protein domain signatures
from Interpro (Mulder et al. 2005) that could be associated with any
one of the downloaded Ensembl Gene IDs. We also identiﬁed 2542
disease descriptions from Online Mendelian Inheritance in Man
[OMIM (Hamosh et al. 2005)] that were assigned to Ensembl Gene
IDs. Phenotype terms from the Mammalian Phenotype Ontology
(Smith et al. 2005) were downloaded and transferred from M. mus-
culus to human via a homology mapping as provided by Mouse
Genome Informatics (Eppig et al. 2007); because many of the pheno-
type terms are quite speciﬁc and have a nearly one-to-one mapping to
GO BP terms, we limited our use of phenotype terms to only those at
the top level of the phenotype ontology: 34 such terms mapped to our
Ensembl Gene IDs. Phylogenetic proﬁles were built for each gene on
the basis of ortholog presence in the genome of any of 38 possible
organisms, as determined by the default threshold used by InParanoid
(O’Brien et al. 2005). The 21,341 genes used in this study had at least
one “gene-centric” feature listed previously.
Correlation coefﬁcients were computed for pairs of genes using all
Affymetrix HG-U133A (PL96) GEO (Barrett et al. 2009) datasets for
which CEL ﬁles were available (97 datasets in total). Each dataset was
preprocessed separately using GCRMA background correction, nor-
malization, and probeset summarization (Wu et al. 2004), with pro-
beset-to-gene mappings provided by BrainArray Custom CDFs
(Version 11) (Dai et al. 2005). Minimum-jackknife-1 Pearson corre-
lation coefﬁcients were computed for each gene-pair in each of the 97
datasets. The 35,948 protein interactions downloaded from HPRD
(Keshava Prasad et al. 2009) were mapped to Ensembl Gene IDs;
ﬁltering of this dataset to remove homo-dimers left 33,811 protein-
protein interactions within our gene set.
GO terms and associations: Our models were trained using the
human GO associations [from the GOA project (Barrell et al. 2009)]
from August 2008, with associations from May 2009 used for the pro-
spective evaluation. All IEA associations were removed, and the remain-
ing associations were up-propagated through the GO graph. Only those
4333 GO terms with at least 3 and at most 300 distinct (non-IEA) gene
associations were included for this study. We used the 8416 genes con-
taining some non-IEA association to any one of these terms as the
training set of genes, with the remaining 12925 genes being the undeter-
mined set. Terms were divided into 12 categories, as described previously.
Model construction and evaluation
GBP models:In total, we used 8735 gene-centric predictive features:
6121 distinct InterPro IDs, 2542 OMIM Morbid Map IDs, 34
Mammalian Phenotype Ontology IDs, and 38 species used to build
phylogenetic proﬁles. Collectively, we call these the GBP feature set.
For each GO term, we trained a separate random forest classiﬁer as
an ensemble of 100 recursive partitioning or decision tree classiﬁers,
using the GBP feature set and the training set of genes as gold-
standard positive examples. The classiﬁers produced scores for each
gene/term combination: predictive scores for undetermined genes,
and out-of-bag (OOB) scores2 for training genes. Precision-vs-recall
performance using OOB scores was calculated for each GO term, then
combined by term category to obtain aggregate measures of perfor-
mance over all GO terms (supporting information, Figure S1).
GBA models: Twelve GBA classiﬁers were built (one for each GO
term category), with each producing a separate FLN that provides





scores). Here again we used random forests, but in this case the set
of objects to be scored consisted of gene pairs (rather than genes).
Among the 8416 training-set genes, gene pairs that shared any GO
term within the same category were used as positive training examples
of functionally-linked genes. To illustrate by example, our BP [31,100]
FLN was constructed using gene pairs that shared any one (or more)
associations to any BP term with fewer than 101 (non-IEA) total
associations. Such pairs were deemed functionally linked and given
a score of “1” in the training network. All remaining pairs among the
8416 training genes were considered not to be functionally linked
(with respect to the current GO term category) and were scored as
“0” in the training network. Predictions of edge weights for all other








¼ 192298150 pairs) are then





OOB edge scores for the training edges are
used for assessing model performance (described below).
For each of our Interpro, OMIM, Mammalian Phenotype
Ontology, and phylogenetic tree datasets, shared patterns of annota-
tion between pairs of genes were scored using a method that is
functionally similar to the PhenoBlast score used previously for
measuring similarity between pairs of Caenorhabditis elegans strains
(Gunsalus et al. 2004). The score between two genes is computed as P​ f 2
i , where fi is the frequency of the i-th feature shared by both
genes. Each such score was then discretized by placing gene-pairs into
bins corresponding to the membership in the top 10%, 20%, 30%,
40%, and 50% quantiles. Thus, each of these datasets led to ﬁve binary
features used in training our functional-linkage models.
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Protein Reference Database (HPRD) are included as a predictive feature.
Each expression dataset was also discretized by using the top 1%, 5%, and
10% quantiles, leading to three binary features per expression dataset.
To make individual gene/term predictions from our FLNs, we use
a probabilistic approach. For GO terms in evaluation categories with
association counts in the ranges [11, 30], [31, 100], and [101, 300], we
compute gene/term scores one term at a time, starting by identifying
the “core set” of genes that have positive associations with the current
GO term. A probability density function is constructed from the edge
weights between all pairs of genes in the core set (forming a clique),
using a Gaussian kernel density estimation (the “core-to-core” distri-
bution). A “pseudo-count-like” edge weight uniformly distributed
over [0,1] is added to this collection to prevent the density estimators
from dropping to zero during numerical computations with a reason-
able kernel bandwidth. Similarly, the weights between all pairs of
noncore training genes and the core set of genes are used to estimate
a “noncore-to-core” distribution. Finally, a gene not in the training set
is scored (for the current GO term) by identifying all edges between
that gene and core set genes; the log-likelihood ratio (LLR) of these
edges having arisen from the “core-to-core” relative to the “noncore-
to-core” distributions is then computed using the estimated probabil-
ity density functions.
For GO terms with 10 or fewer gene associations, the process is
similar to that described, except that “core-to-core” and “noncore-to-
core” distributions are estimated from core-to-core and noncore-to-
core gene-pair sets pooled across all GO terms in the evaluation
category. We selected this method after empirical observation that
the limited number of core genes for many such GO terms led to
poor density function estimation (results not shown).
Performance of annotation transfer by LLRs was estimated using
a leave-one-out (LOO) approach: each gene in the training set was
scored using the OOB edge weights computed during random forest
construction, and distributions were re-estimated after excluding all
edges incident to the current held-out gene. The transferred LOO
scores for each GO term were then evaluated similarly to the scores
produced by the GBP models (Figure S2).
Combined models: We combined the GBA and GBP scores for each
gene/term via logistic regression, referring to the combined scores as
“HF” scores. The general form of the combination is:
LOHF
i ¼ a   LLRGBP
i þð 12aÞ LLRGBA
i þ LOprior;
where LOHF
i is the posterior HF log-odds and LLRGBP
i and LLRGBA
i
are the log-likelihood ratios of the GBP and GBA models, all for
each gene i. LOprior is the prior log-odds of a gene being associated
with a particular term (invariant across genes for each term).
The a-term in the aforementioned equation is systematically op-
timized to maximize the LOO estimates of the area under the PR
curve (average precision) for each term. For GO terms in evaluation
categories with association counts in the ranges [11,30], [31,100], and
[101,300], the a coefﬁcients are determined separately for each GO
term. To avoid overﬁtting the coefﬁcients for the GO terms in
Figure 1 General strategy for the combined GBP and
GBA approach. (GBP: guilt-by-proﬁling, GBA: guilt-by-
association, HF: human function, FLN: functional-linkage
network.)
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for all GO terms within the category (i.e. aBP[3,10], aCC[3,10], aMF[3,10],).
Prospective evaluation
For prospective evaluation, each term was evaluated individually (as
mentioned previously), but with changes to the set of genes used for
the evaluation. First, all existing positive associations made prior to the
start date were removed from each term’s list of gene scores. Second,
only those genes that received any association (i.e.,t oa n yo t h e rt e r m
in the GO) in the time since the start date were retained; there were
1170 such genes. The idea here is that any new association for a gene
made in the prospective time window indicates that this gene had
some curation done and thus had the opportunity to be newly asso-
ciated with at least one term (and possibly more). Genes not receiving
any new association in that time window were not considered for
prospective validation. Aggregate prospective performance across all
GO terms is shown in Figure 6.
Selection of 36 predictions for literature follow-up
Three gene/term pairs from each of the term categories were chosen for
a literature-based follow-up. We considered only gene/term pairs for
which the gene had no known or predicted (i.e., IEA-based) function
within the same GO branch—we call these “novel” predictions. The
top three HF scores within each term category after this ﬁltering were
then chosen. A list of these 36 predictions, along with their assessments
and literature references, is available as Supplementary Information.
Microarray differential expression analysis
When evaluating differential expression for our glioma network
follow-up, we used Welch’s two sample t-tests, followed by a multi-
ple-testing correction (Benjamini and Hochberg 1995). We note that
the Bredel et al. (2005) dataset was not included as part of our micro-
array co-expression data set used for training our FLNs (to address
circularity in the discovery process).
Computational tools
Random forest code was written in Java for this study, and all
statistical analyses (e.g., model performance estimates) were per-




All data collected were from public sources and fell into the two broad
classes of gene property and gene-pair relationship (Figure 1, Table 1,
Table 2), and 4333 GO terms were chosen for classiﬁcation (see
Materials and Methods for a description of the selection criteria).
Terms were separated into 12 distinct term categories on the basis
of the aspect of function it describes, that is, biological process (BP),
cellular component, or molecular function (MF), and its breadth, that
is, the number of unique genes to which it has been assigned ([3,10],
[11,30], [31,100], or [101,300] non-IEA associations, following the
paradigm introduced in Pena-Castillo et al. 2008, Table 3). These
distinctions allow us to separately study inferences to GO terms of
similar “type” and permit an understanding of how performance
differs among these types. Gene features and GO term associations
were gathered in 2008, with the prospective evaluation reported here
based on term associations made approximately 1 year later (2009).
All associations with IEA evidence codes were removed from this
study (forcing our models to rely on ground truth rather than on
previous predictions), with the remaining association types used for
model training being distributed as shown in Figure 3.
Quantitative association of 21,341 H. sapiens genes to
4333 GO terms
Predictions of gene/term associations were made by combining GBP
and GBA approaches. Quantitative scores describing the strength of
association between each GO term and human gene were computed
(for a total of 4333 21,341 ~ 92 · 106 gene/term scores).
In the GBP approach (relying on “gene-centric” data), a separate
random forest classiﬁer (Breiman 2001) was constructed for each GO
term, providing direct gene/term predictions that we call the “GBP
set.” The GBA approach is complementary to GBP in that it focuses
on “transferring” annotation from one gene to another via evidence of
a biological relationship between the genes. To this end, data best
represented as “edge-centric” (e.g., protein2protein interactions) were
used to construct FLNs, graphs describing relationships (edges) be-
tween genes (vertices), where edge weights reﬂect conﬁdence levels of
two genes sharing a function (Lee et al. 2004). We constructed 12
probabilistic FLN networks (one for each of the aforementioned 12
categories), also using random forests (one per FLN). Associations
between each gene g and each term t were then transferred probabi-
listicallybyexaminingthestrengthofconnectionbetweeng anda ‘core
set’ of genes already annotated with term t (details in Materials and
Methods). The collection of gene/term scores derived from this pro-
cess is called the “GBA set.”
Finally, the GBP and GBA scores were combined for each GO
term via a logistic regression model optimized to maximize precision
vs. recall (PR) performance (see Materials and Methods), resulting in
the human function (HF) set of quantitative conﬁdence scores.
Predictive performance
Our predictions were evaluated (using a cross-validation scheme) for
each term, and for all three sets of scores (GBP, GBA, and HF). To
obtain a global view of performance, evaluation measures were
Figure 2 Distinct Ensembl Gene IDs grouped into broad classes
depending on status of association with at least one GO term.
n Table 1 Number of distinct genes (21,341 total genes) with at
least one “gene-centric” feature attributed to it for each predictive
data type
Data Type No. Genes No. Features
Domain signature pattern 15,274 5063
MIM disease association 1765 2125
Phylogenetic proﬁle 20,964 38
Phenotype association 5162 34
MIM, Mendelian Inheritance in Man.
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analysis that shows the characteristic trade-off of accuracy vs. recovery
f o rp r e d i c t i v em o d e l s( F i g u r e4 ,Figure S1,a n dFigure S2). For a given
score threshold t, precision is the proportion of (known) “true” gene/
term pairs among all gene/term pairs scoring above t; recall is the
proportion of “true” gene/term pairs scoring above t among all possi-
ble “true” gene/term pairs. The combination of GBP and GBA scoring
methods provide an increase in average precision for many different
term types (insets of Figure 4). We also ﬁnd that our performance (in
terms of precision) compares favorably with the best performance
achieved from the MouseFunc study (Figure 5), with mean precision
at 20% recall (P20R) ranging between approximately 20% and 70%.
Our HF predictions were also evaluated prospectively using gene/
term associations made after the start date. Because all genes will not
have been studied in this time window (and thus not given the op-
portunity to gain new annotations), we evaluated performance for the
subset of 1170 genes that gained at least one new GO annotation
during this period (Figure 6). Recall for each term was calculated using
only gene/term pairs recently (i.e., in the time window) assigned to
that term. For lower recall levels (e.g., ,20%), our precision generally
ranged between 20% and 40%.
Literature-based validation of top novel predictions
Having evaluated the performance of quantitative annotations by
cross-validation and prospective analysis, we wished to more carefully
examine the most interesting HF predictions, that is, those that are
both novel and most likely to be correct. To restrict ourselves to the
most novel predictions, we excluded any predictions in which the gene
had previously been annotated to any GO term in the same branch as
the predicted GO term. We further excluded gene/term pairs that had
previously been predicted (on the basis of annotation with an IEA
evidence code). For each of the 12 GO categories, we examined
literature related to the three top-scoring novel predictions, leading to
36 high-scoring gene/term predictions from the HF model for in-
depth literature evaluation.
Of the predictions examined, we deemed 14 to be “true” or “likely
true” (9 and 5, respectively) given evidence available in the current body
of published literature. The success rate corresponds to 14 of 36 (39%)
and thus appears similar to our prospective estimates of precision (de-
scribed previously). Of the remaining predictions, 14 were unclear, in that
we found no existing literature that either supported or refuted the pre-
diction. These predictions can be viewed as hypotheses for further study.
The ﬁnal 8 predictions were either “likely false” (6) or “false” (2). (A full
list of the 36 literature-evaluated predictions and chosen categories, with
PubMed IDs, where available, is provided in File S1 f o rt h i sa r t i c l e . )
FLNs for functional gene set expansion
In addition to their contribution toward predicted gene/term
associations, FLNs have previously been shown to be valuable tools
for elucidating relationships between genes [e.g., predicting genetic
interactions via patterns of functional linkage (Lee et al. 2010)]. We
further ﬁnd that FLNs are useful for identifying disease-associated
candidates by extracting subsets of genes that were functionally linked
with particular seed genes of interest.
As an example of how “induced subgraphs” from FLNs can aid in
annotation of genes even in the absence of any particular seed set of
genes, we selected the single gene POLR2J2, which was found to be
“likely true” in the aforementioned literature evaluation for association
with the GO MF term “DNA-directed RNA polymerase complex”
(GO:0000428). Considering only the edges scoring in the top 0.1%
of the FLN for the term category BP [3,30], the 3 linked neighbors of
POLR2J2 are POLR2J3, POLR2J,a n dPOLR1C (Figure S3). The non-
seed genes with preﬁx POLR2J are each subunits of the RNA Pol II
complex, and POLR1C is a subunit of the RNA Pol I complex. We
note that POLR2J2 has no cataloged interaction partners in the HPRD
(Keshava Prasad et al. 2009), limiting the prospects of GBA via phys-
ical or genetic interactions alone. Although this is a case of an already
named and characterized gene, it serves to illustrate the (1) automated
identiﬁcation of strong functional hypotheses and (2) identiﬁcation of
groups of additional genes enriched for functional relationships with
a particular incompletely annotated gene of interest.
To illustrate how one may use FLNs to identify novel candidate
disease genes [an idea supported by recent similar work in ref. (Lee
et al. 2011)], we examined a seed set of candidate genes identiﬁed
from a meta-analysis of GWA studies examining glioma susceptibility
(Shete et al. 2009). Five of the six genes identiﬁed by the meta-analysis
n Table 2 Number of distinct genes (of 21,341 total genes)
appearing in at least one “gene-pair-centric” data type
Data Type No. Genes
Expression proﬁles 11911
Interaction evidence 7725
Details of how each such data type is split into predictive features are given in
Materials and Methods.
n Table 3 Number of terms in each of the 12 evaluation
categories
Num Assoc BP CC MF
[3,10] 1490 234 686
[11, 30] 694 121 231
[31, 100] 374 85 158
[101, 300] 177 34 49
BP, biological function; CC, cellular component; MF, molecular function.
Figure 3 Counts of association types between Ensembl Gene IDs and
GO terms (by GO evidence code). The barplot represents the
evidence code distribution within the smaller (non-IEA) slice of the pie.
Volume 2 February 2012 | Quantitative H. sapiens Functional Annotation | 227Figure 4 Aggregated HF performance for each of the 12 GO term categories. Contour lines indicate the fraction of GO terms that met or
exceeded each cumulative precision vs. recall performance point. Contours are shown for median GO term (50% contour; heavy blue dashed line)
and every other decile of GO terms. The mean performance (heavy blue solid line is also shown. Gray area exceeds performance of all classiﬁers.
Red and green lines indicate median and mean performances (dashed and solid, respectively) for GBP and GBA classiﬁers. The median of average
cumulative precision across all classiﬁers in each category is shown in inset (error bars show standard error of the median).
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seeds in the BP [3,30] FLN with an edge-weight threshold retaining
only the top 0.01% of edges. The resulting subgraph induced by this
seed set of ﬁve glioma-associated genes recruited 21 additional genes
(Figure 7). Genes common to many forms of cancer were among
those found (e.g., BRCA2, TP53, CDK4, XRCC4,n o n eo fw h i c hw e r e
seeds originating from the GWAS meta-analysis). Two seed-centered
components (one from the seed TERT, the other from the seeds
CDKN2A and CDKN2B) are connected via a functional link between
the two nonseed genes BRCA2 and NBN. This approach generalizes
the strategy of inducing disease networks from known disease-associ-
ated seed genes using physical interaction data (Pujana et al. 2007).
To illustrate the greater potential for detection of related genes
when FLNs are used, as opposed to using only protein interactions
alone, we also display (Figure 7) all interactions cataloged in HPRD
between the 26 genes in our glioma network. Among interesting
candidate genes retrieved using the FLN, the NBN gene had previously
been postulated to have a role in nonglioma forms of cancer, and
recent evidence has (independently from the GWA studies) impli-
cated NBN variants in pediatric glioblastoma (Piekutowska-Abramc-
zuk et al. 2009). Also of interest is the recovery of the LRP5 gene,
a low-density lipoprotein receptor-related protein that has been iden-
tiﬁed as potentially oncogenic (Li and Bu 2005) and part of the can-
cer-drug-targeted Wnt/beta-catenin signaling pathway (Luu et al.
2004). We note that both the NBN and LRP5 genes would not have
been recovered using the HPRD interaction network alone (with a “1-
nearest-neighbor” expansion). To further analyze the value of our
glioma network, we examined a microarray expression dataset from
an experiment comparing (among other tumor types) glioblastoma
samples and normal brain tissue [(Bredel et al. 2005) NCBI GEO
(Barrett et al. 2009) record GDS1813]. Of the 21 genes in our glioma
network for which we could compute test statistics, we found that 10
show differential expression (FDR , 0.1), including the NBN and
LRP5 genes, shown in Figure S4.
Resource availability
Our predictions are made available as a resource to the community via
an online web-accessible and searchable browser (Beaver et al. 2010),
available via http://func.mshri.on.ca/human, with periodic data updates
(trained on current gene annotations). Our FLNs, not included in the
File S1 because of ﬁle size constraints, are available for download at
http://llama.mshri.on.ca/~mtasan/HumanFunc_publication_support.
DISCUSSION
Combining GBP and GBA methods allows full
data exploitation
Our quantitative gene function annotations combine both gene-centric
and gene-pair relationship evidence. The contribution of relationship-
based (GBA) scoring tends to increase as the terms become more
speciﬁc. Given that gene-centric (GBP) models are trained separately
for each GO term, it stands to reason that performance must degrade
for GO terms with very few annotated genes to use as positive training
examples. By contrast, FLNs are trained by aggregating information
from many related GO terms. This lends support to the notion of
using the FLNs for inferring speciﬁc functions. Also we ﬁnd that terms
in the MF (molecular function) branch of the GO vocabulary often
rely more heavily on the GBP scores; this is likely to be due, at least in
part, to the strong association between protein domain pattern
signatures and speciﬁc biochemical functions.
Emphasis on high precision at low recall
We expect that a common use of this resource will be experimental
biologists examining only the top few quantitative annotations for any
Figure 5 Comparing current performance with previous
mouse gene function predictions. Precision at 20%
recall for best-performing groups of the MouseFunc
project (Pena-Castillo et al. 2008) was compared with
HF scores in this study. Differences reﬂect a combination
of both algorithms and datasets used but indicate that
overall prediction performance is at least comparable
and for some term categories represents a substantial
improvement. Error bars indicate standard error of the
mean; variance across terms for MouseFunc not avail-
able, preventing error bar computation.
Volume 2 February 2012 | Quantitative H. sapiens Functional Annotation | 229Figure 6 Prospective evaluation of precision vs. recall. Predictions made on July 19, 2008, evaluated on new associations made between July 19,
2008, and May 28, 2009. Dashed lines indicate each 10% contour, heavy dashed line is median (50% contour), and the heavy blue solid line is
mean performance. Contours indicate what fraction of classiﬁers in the evaluation category exceeded the shown performance. Gray area exceeds
performance of all classiﬁers.
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a ranked list of annotations, each in the context of underlying
evidence, permits ﬁltering based on (often extensive) user knowledge
that was not modeled by our approach. Thus, our GBP and GBA
predictions are combined to maximize average precision, which is
largely driven by the accuracy of the top predictions.
Cross-validation vs. prospective performance evaluation: Differ-
ences between the training performance estimates and the prospective
estimates reﬂect both the bias in the state of the associations at the
start date (i.e., some genes and terms are better-studied than others)
and the types of genes and terms recently curated by GOA. Even
limiting the evaluated genes to those that have gained some new
annotation in the time period, there are several reasons why one might
expect to see lower precision-recall performance for the prospective
evaluation as compared to that seen with cross-validation. First, each
freshly-annotated gene gained an average of only 3.1 new GO term
associations, which is lower than the total number of terms that we
might ultimately expect to be added for each gene. Second, recently-
annotated functions may be intrinsically harder to predict (i.e.,w h e r e
the function is obvious, annotations will tend to occur at an earlier
time). Third, recent advances may be on functions that were less well-
studied previously, so that the training data are sparsely available or is
not representative.
Variable importance
As part of our GBP process, we obtain a variable importance measure
for each predictive feature, measuring that feature’sc o n t r i b u t i o nt o
the performance of the classiﬁer. These can assist in understanding
why a prediction has been made, possibly suggesting a validation
experiment or simply providing more general clues to help guide
the researcher. Strong evidence of particular features leading to accu-
rate gene/term associations may lead to the establishment of empiri-
cally derived annotation-transfer rules. As an example, the gene
RAET1L was predicted to have MHC class I receptor activity, and
based solely on the available literature, this prediction was deemed
“unclear.” That two of the top three Interpro protein domain pattern
signatures with high importance for predicting MHC class I receptor
activity had been assigned to this gene (a MHC class I alpha chain
pattern (IPR001039) and a MHC classes I and II-like antigen recog-
nition pattern (IPR011162)) yields insight into why this prediction
was made, and can guide curators in their decision on whether to
make a GO term association for this gene. Such feature identiﬁcation
can also be used to help streamline future prediction efforts [by fo-
cusing efforts on those predictive features that are most informative
for the task at hand (Ko and Lee 2009)].
A novel method for annotation transfer through FLNs
To derive GBA scores for each term, we use the edge weights of the
appropriate FLN to transfer associations from genes currently
associated with that term (the “core set”) to those genes with “un-
known” association status. This process calculates, for each candidate
gene in turn, a likelihood ratio that measures whether the distribution
of weights connecting the candidate to the core set is more consistent
with ‘core-to-core’ pairs (that are known to share the function) than
‘core-to-non-core’ pairs (that are not known to share the function; see
Material and Methods for details). We have previously experimented
with other forms (see Wang and Marcotte 2010 for a review) of
association transfer from FLNs, speciﬁcally, using average weight of
(the top-n) edges linking “unknown” genes to “core set” genes (Tian
Figure 7 Illustrated use of the human
FLN to identify additional candidate
genes from a set of seed genes. This
network was identiﬁed using ﬁve gli-
oma genes identiﬁed in unbiased ge-
nome-wide association studies (in red).
The FLN used was the top 0.01% of
edges (in red) from the BP [3,30] FLN.
To illustrate that the FLN extends
beyond known protein interactions,
all cataloged HPRD interactions be-
tween these 26 genes are shown as
blue edges.
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approach applied here to be more robust and empirically better-per-
forming than the ‘top-n’ approach in cross-validation evaluation
(results not shown).
Utility of FLNs
Physical interaction networks have been shown to help transfer gene
function (Schwikowski et al. 2000; Letovsky and Kasif 2003; Gunsalus
et al. 2005), and extending these approaches to include predicted
functional interactions can drastically increase the power of discovery.
The STRING database (Szklarczyk et al. 2011) is an example of a pub-
licly accessible repository of predictions of functional interactions
made through various evidence sources (e.g., literature co-citation or
existing protein2protein interaction reports). Our functional linkage
networks differ from those in STRING in that we make predictions for
all pairs of genes at different levels of resolution and with respect to
different types of functional links (e.g.,B P —a shared role in some
biological process vs. MF—sharing a particular molecular activity).
When comparing the STRING (v9.0) interaction scores with those
of each of our 12 FLNs, we see a signiﬁcant correlation in each case
(P , 3 · 10212 for all 12 correlations measured). However, these
correlations were relatively weak, with Pearson correlations ranging
from r = 0.07 (category cellular component [3,10]) to r =0 . 2 0( c a t -
egory MF [3,300]). Although STRING provides highly reliable func-
tional associations between genes, it is limited to only those pairs with
strong scores (~3.3 million in STRING v9.0, as opposed to the ~200
million in each of the 12 FLNs described previously). A larger range of
scores can provide additional information, for instance, establishing
densities of scores for use in label propagation (as described in the
section A novel method for annotation transfer through FLNs), thus we
see a continued role for our FLNs in ongoing research.
Biological networks can reveal previously unknown players in the
etiology of a phenotype, solely based on of their proximity in a FLN to
known genes associated with the phenotype. For example, a seed set of
genes associated with breast cancer has been successfully used to
identify additional disease genes via protein interaction relationships
(Pujana et al. 2007). Here we extend this notion in two ways: First, we
use edges that aggregate multiple sources of evidence about pairwise
functional relationships. Second, our predictive models include essen-
tially all genes, including those that have neither existing physical
interaction evidence nor existing GO annotations.
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